NSW Children To Get Compassionate Access To Cannabis Based Drug

by Dr. Meenakshy Varier on  July 6, 2016 at 11:17 AM Clinical Trials News   - G J E 4
A group of forty children will get primary access to cannabis based treatment for epilepsy in Australia's first clinical trial.
NSW Children To Get Compassionate Access To Cannabis Based Drug
NSW Children To Get Compassionate Access To Cannabis Based Drug

Epidiolex, an orally-ingested formulation of pure cannabidiol which is a non- psychoactive component of marijuana, is to be used on children in New South Wales suffering from the most severe, treatment-resistant epilepsy where all conventional form of treatments have failed.

‘Children suffering from drug-resistant, severe cases of epilepsy to be given respite through cannabis based clinical trials.’
The medicine which the NSW government has secured from the United Kingdom will be distributed through Sydney's Children Hospital. The Therapeutic Goods Administration has authorized specialist paediatric neurologists working in NSW public hospitals to prescribe Epidiolex.

NSW Premier, Mike Baird has said that initially the trial would be limited to the sickest of the sick who are dealing with the most severe cases of epilepsy. Clinicians would contact the eligible families of children and monitor the children receiving the drug for a period of twelve weeks.

The trial would be expanded within the next twelve months. For every three out of ten children, the drug may yield significant benefits, while it may turn out miraculous for one in ten.

This trial holds a promising future for other cannabis based drug trials.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like